Cognitive behavioural therapy, including acceptance and commitment therapy (ACT), is recommended as part of a multimodal approach to the management of fibromyalgia. The phase III PROSPER-FM trial has now shown that a self-guided smartphone-based ACT programme is safe and improves clinical outcomes in adults with fibromyalgia.

ACT aims to enhance patients’ capacity to adapt to challenges and achieve personal goals, leading to changes in their reaction to symptoms. In the PROSPER-FM trial, 275 participants across 25 centres in the USA were randomly assigned to receive digital therapy with the Stanza ACT app or with an active control app that offered daily symptom and function tracking and access to relevant educational materials.

认知行为疗法，包括接受和承诺疗法（ACT），被推荐作为纤维肌痛治疗多模式方法的一部分。 III 期 PROSPER-FM 试验现已表明，基于智能手机的自我引导 ACT 计划是安全的，并且可以改善患有纤维肌痛的成人的临床结果。

ACT 旨在增强患者适应挑战和实现个人目标的能力，从而改变他们对症状的反应。在 PROSPER-FM 试验中，美国 25 个中心的 275 名参与者被随机分配接受使用 Stanza ACT 应用程序或主动控制应用程序的数字治疗，该应用程序提供每日症状和功能跟踪以及相关教育材料的访问。